La Prensa MedicaISSN: 0032-745X

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Asma A Swadi Author

Subjects of specialization
ADRB1 polymorphism , Metoprolol, Acute coronary syndrome

Affiliation
Department of Pharmacology and Therapeutics, College of Medicine, University of AL-Qadisiyah, Iraq

Biography

Asma A Swadi, belongs to Department of Pharmacology and Therapeutics, intrested in the field of ADRB1 polymorphism; Metoprolol; Acute coronary syndrome ?from College of Medicine, University of AL-Qadisiyah, Iraq


Publications

Research Article Open Access

A Comparative Study to illustrate the Effects of Beta-1 Adrenergic Receptor Allelic Polymorphism on Disease Outcome in Iraqi Patients with Acute Coronary Syndrome (on Metoprolol Therapy)

Author(s):

Asma A Swadi, Bassim I Mohammad, Najah R Hadi and Hayder Al-Aubaidy

Objective: The response to metoprolol therapy in patients with acute coronary syndrome (ACS) is variable and a substantial element of this variability is linked to variation in CYP2D6 enzyme and adrenoreceptor (ADRB1) alleles, genotype polymorphism, affecting the phenotype in terms of both rate of metabolism of the active metoprolol (and hence its metabolic ratio) and the responsiveness of ADRB1 receptors to bound metoprolol. This study aims to investigate different clinically relevant allele variants (allele frequencies) of ADRB1 genes: (Arg389Gly: Gly/Gly, Gly/Arg, Arg/Gly) and to determine whether a specific genotype of Beta-1 adrenergic receptor genes (based on genetic polymorphism "allelic types" and combination) have impact on metoprolol effectiveness (clinical outcome) in Arabic ... view moreĀ»

Abstract PDF



Social Media


Google Scholars / Researchers Sites

GET THE APP